Survey: 560 Products Developed Since April; GSK And Chugai Top Anti-Cancer Drugs; Takeda Makes Breakthrough
This article was originally published in PharmAsia News
Executive Summary
Among 560 new products developed by 64 pharmaceutical companies, anti-cancer drugs comprise one-third of the drugs.